Evidence map›Paper›PMID 37261885›Full record

ArticleJMIR cancer2023

Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study.

Elizabeth Y Wang, Hala T Borno, Samuel L Washington Iii, Terence Friedlander, Sylvia Zhang, Evelin Trejo, Erin L Van Blarigan, June M Chan, Salma Shariff-Marco, Alexis L Beatty and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05324098 (Leveraging Technology), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05324098 nacompletednot on this map

Leveraging Technology (STAND-T) to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

TypeinterventionalSponsorUniversity of California, San FranciscoRan2022 to 2023Enrolled47ConditionsProstate CancerArmsSTAND-T platform, Survey Administration, Text Messages
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Elizabeth Y Wang *University of Hawaii, Honolulu, HI, United States.ORCID https://orcid.org/0000-0001-5226-7258
Hala T Borno *Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-4357-9759
Samuel L Washington IiiDepartment of Urology, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-2467-6115
Terence FriedlanderDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-3630-4941
Sylvia ZhangDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0001-6106-038X
Evelin TrejoZuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0003-4885-5182
Erin L Van BlariganDepartment of Urology, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0001-5079-3385
June M ChanDepartment of Urology, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-7620-569X
Salma Shariff-MarcoDepartment of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-2541-3333
Alexis L BeattyDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0001-8405-7386
Stacey A KenfieldDepartment of Urology, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-1585-7352
University of California, San Francisco · USSan Francisco General Hospital · USUniversity of Hawaiʻi at Mānoa · US

Funding

UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
NIDDK NIH HHS P30 DK098722
6 · The paper itself

Abstract

backgroundHealthy diet and exercise can improve quality of life and prognosis among men with prostate cancer. Understanding the perceived barriers to lifestyle change and patient preferences in a diverse cohort of men with prostate cancer is necessary to inform mobile health (mHealth) lifestyle interventions and increase health equity.

objectiveWe conducted a multisite study to understand the preferences, attitudes, and health behaviors related to diet and lifestyle in this patient population. This report focuses on the qualitative findings from 4 web-based focus groups comprising a racially and ethnically diverse group of patients with advanced prostate cancer who are on androgen deprivation therapy.

methodsWe used grounded theory analyses including open, axial, and selective coding to generate codes. Qualitative data were analyzed as a whole rather than by focus group to optimize data saturation and the transferability of results. We present codes and themes that emerged for lifestyle intervention design and provide recommendations and considerations for future mHealth intervention studies.

resultsOverall, 14 men participated in 4 racially and ethnically concordant focus groups (African American or Black: 3/14, 21%; Asian American: 3/14, 21%; Hispanic or Latino: 3/14, 21%; and White: 5/14, 36%). Analyses converged on 7 interwoven categories: context (home environment, access, competing priorities, and lifestyle programs), motivation (accountability, discordance, feeling supported, fear, and temptation), preparedness (health literacy, technological literacy, technological preferences, trust, readiness to change, identity, adaptability, and clinical characteristics), data-driven design (education, psychosocial factors, and quality of life), program mechanics (communication, materials, customization, and being holistic), habits (eg, dietary habits), and intervention impressions. These results suggest actionable pathways to increase program intuitiveness. Recommendations for future mHealth intervention design and implementation include but are not limited to assessment at the individual, household, and neighborhood levels to support a tailored intervention; prioritization of information to disseminate based on individuals' major concerns and the delivery of information based on health and technological literacy and communication preferences; prescribing a personalized intervention based on individuals' baseline responses, home and neighborhood environment, and support network; and incorporating strategies to foster engagement (eg, responsive and relevant feedback systems) to aid participant decision-making and behavior change.

conclusionsAssessing a patient's social context, motivation, and preparedness is necessary when tailoring a program to each patient's needs in all racial and ethnic groups. Addressing the patients' contexts and motivation and preparedness related to diet and exercise including the household, access (to food and exercise), competing priorities, health and technological literacy, readiness to change, and clinical characteristics will help to customize the intervention to the participant. These data support a tailored approach leveraging the identified components and their interrelationships to ensure that mHealth lifestyle interventions will engage and be effective in racially and ethnically diverse patients with cancer.

trial registrationClinicalTrials.gov NCT05324098; https://clinicaltrials.gov/ct2/show/NCT05324098.

Indexed as

androgen deprivation therapycancer survivorshipdigital healthmetastaticmobile phonemodifiable behaviorsrace and ethnicitysocial determinants of healthtechnology-based intervention

Identifiers

PMID37261885
PMCPMC10273032
OpenAlexW4362500934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.